Prevalence of age-related macular degeneration in the US population.
暂无分享,去创建一个
R. Klein | B. Klein | S. Meuer | J. Saaddine | Xinzhi Zhang | Chiu-fang Chou | R. Klein
[1] R. Klein,et al. The Wisconsin age-related maculopathy grading system. , 1991, Ophthalmology.
[2] R. Klein,et al. Forecasting age-related macular degeneration through 2050. , 2009, JAMA.
[3] D. Friedman,et al. Racial differences in the prevalence of age-related macular degeneration: the Baltimore Eye Survey. , 1999, Ophthalmology.
[4] Sharon D. Solomon,et al. Racial differences in the prevalence of age-related macular degeneration: the Salisbury Eye Evaluation (SEE) Project. , 2008, Archives of ophthalmology.
[5] R. Klein,et al. The prevalence of age-related maculopathy by geographic region and ethnicity. The Colorado-Wisconsin Study of Age-Related Maculopathy. , 1997, Archives of ophthalmology.
[6] P. Mitchell,et al. Smoking and age-related macular degeneration: a review of association , 2005, Eye.
[7] E. Souied,et al. [Epidemiology of age related macular degeneration]. , 2009, Journal Francais d'Ophtalmologie.
[8] R. Klein,et al. Prevalence of age-related macular degeneration in a population-based sample of Hispanic people in Arizona: Proyecto VER. , 2005, Archives of ophthalmology.
[9] Ronald Klein,et al. The epidemiology of age-related macular degeneration. , 2004, American journal of ophthalmology.
[10] R. Klein,et al. Birth cohort effect on prevalence of age-related maculopathy in the Beaver Dam Eye Study. , 2003, American journal of epidemiology.
[11] R. Klein,et al. Prevalence of age-related maculopathy in the Atherosclerosis Risk in Communities Study. , 1999, Archives of ophthalmology.
[12] R. Klein,et al. Physical activity and the 15-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study , 2006, British Journal of Ophthalmology.
[13] G. Foster,et al. National Health and Nutrition Examination Survey , 2005 .
[14] D. Holt,et al. Methods of weighting for unit non-response , 1991 .
[15] R. Klein,et al. Age-period-cohort effect on the incidence of age-related macular degeneration: the Beaver Dam Eye Study. , 2008, Ophthalmology.
[16] R. Klein,et al. The relationship of age-related maculopathy, cataract, and glaucoma to visual acuity. , 1995, Investigative ophthalmology & visual science.
[17] V. Preedy,et al. National Health and Nutrition Examination Survey , 2010 .
[18] S C Jensen,et al. Age-related maculopathy in a multiracial United States population: the National Health and Nutrition Examination Survey III. , 1999, Ophthalmology.
[19] R. Klein,et al. Prevalence of age-related macular degeneration in Latinos: the Los Angeles Latino eye study. , 2004, Ophthalmology.
[20] R. Klein,et al. Detection of age-related macular degeneration using a nonmydriatic digital camera and a standard film fundus camera. , 2004, Archives of ophthalmology.
[21] J. Saaddine,et al. Forecasting age-related macular degeneration through the year 2050: the potential impact of new treatments. , 2009, Archives of ophthalmology.
[22] S. Blair,et al. Cardiorespiratory fitness levels among US adults 20-49 years of age: findings from the 1999-2004 National Health and Nutrition Examination Survey. , 2010, American journal of epidemiology.
[23] Don H. Anderson,et al. Extended haplotypes in the complement factor H (CFH) and CFH-related (CFHR) family of genes protect against age-related macular degeneration: characterization, ethnic distribution and evolutionary implications. , 2006, Annals of medicine.
[24] R. Klein,et al. Cataracts and macular degeneration in older Americans. , 1982, Archives of ophthalmology.
[25] Don H. Anderson,et al. Extended haplotypes in the complement factor H (CFH) and CFH‐related (CFHR) family of genes protect against age‐related macular degeneration: Characterization, ethnic distribution and evolutionary implications , 2006, Annals of medicine.
[26] R. Klein,et al. Early age-related maculopathy in the cardiovascular health study. , 2003, Ophthalmology.
[27] Jennifer I. Lim,et al. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. , 2001, Archives of ophthalmology.
[28] R. Guymer,et al. Cost-effectiveness of smoking cessation to prevent age-related macular degeneration. , 2008, Cost effectiveness and resource allocation : C/E.
[29] R. Klein,et al. Racial/ethnic differences in age-related maculopathy. Third National Health and Nutrition Examination Survey. , 1995, Ophthalmology.
[30] M. C. Leske,et al. Features of Age-Related Macular Degeneration in a Black Population , 1995 .
[31] R. Klein,et al. Causes and prevalence of visual impairment among adults in the United States. , 2004, Archives of ophthalmology.
[32] M. C. Leske,et al. Nine-year incidence of age-related macular degeneration in the Barbados Eye Studies. , 2006, Ophthalmology.
[33] R. Klein,et al. Prevalence of age-related macular degeneration in 4 racial/ethnic groups in the multi-ethnic study of atherosclerosis. , 2006, Ophthalmology.